Axioma releases new APAC and APAC ex-Japan risk models

Axioma, a RegTech 100 company, has released its new APAC (AP4) and APAC ex-Japan (APexJP4) Risk Models.

These are the newest addition to the company’s equity factor risk model suite and come hot off the heels of its emerging market and China risk models. The tools offer equity investors with deep, actionable insights on how to best manage risk and returns across global growth markets.

Now with the updated risk models, Axioma offers risk attribution precision for more than 26,000 active securities in 17 markets within Asia Pacific. The 4th generation of the models offer new tools including dividend yield, earnings yield, and profitability, which will provide

Axioma managing director Joel Coverdale said, “2018 was a wake-up call for Asian focused investors, with the impact of risk-on / risk-off behaviour in an uncertain global environment a significant headwind to return expectations.

“We want to provide every investor with the best possible insights to know both where they stand and where they might be headed. A best-in-class risk management approach is critical for success.”

Late last year, Axioma was chosen by Legal & General Investment Management to support its risk analytics. Through the partnership, the RegTech offers the firm with the ability to expand their risk analytic capabilities.

In an interview with RegTech Analyst last year, Axioma managing director and head of risk solutions Ian Lumb said the wave of new regulations being deployed is being seen as “just layers of costs on top of the business” by some compliance leaders.

Last year, Axioma was hand-selected for the RegTech 100, by a panel of industry experts. The list compiles all the RegTech companies every financial institution should know about in 2019.

Copyright © 2019 FinTech Global

Enjoyed the story? 

Subscribe to our weekly RegTech newsletter and get the latest industry news & research

Copyright © 2018 RegTech Analyst

Investors

The following investor(s) were tagged in this article.